Lyra therapeutics announces appointment of john bishop, ph.d., as chief technology officer

Watertown, mass., feb. 27, 2023 (globe newswire) -- lyra therapeutics, inc. (nasdaq: lyra) (the company or lyra), a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis (crs), today announced the appointment of john bishop, ph.d., as chief technology officer, effective february 27, 2023. dr. bishop will lead the commercial scale-up of lyra's manufacturing operations for the company's late-stage product candidates, lyr-210 and lyr-220.
LYRA Ratings Summary
LYRA Quant Ranking